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Objectives: Spinal cord ischemia (SCI) after open or
endovascular thoracoabdominal aortic aneurysm (TAAA)
repairs is a serious complication with adverse effects on
quality of life and long-term survival. Many risk factors
for SCI after open surgery have been identiﬁed; however,
the pathophysiology of SCI after endovascular repair is
less understood. Our aim was to identify factors associated
with postoperative SCI after multibranched endovascular
aneurysm repair (MBEVAR) for TAAA.
Methods: From July 2005 to October 2013, 116 pa-
tients with TAAA (30 women; mean age, 73.46 7.7 years)
were treated in a prospective, single-center trial for MBE-
VAR. Symptomatic patients and those with dissection
were excluded. SCI was classiﬁed into lower extremity pa-
ralysis (LEP), permanent lower extremity weakness
(pLEW), and transient LEW (tLEW). Perioperative spinal
cord protection measures included cerebrospinal ﬂuid
(CSF) drainage and permissive hypertension.
Results: Postoperative SCI occurred in 24 of 116 pa-
tients (20.6%). Most patients had tLEW (15 of 116
[12.9%]) with full recovery, and less frequently pLEW (n
¼ 3 of 116 [2.6%]) or LEP (n ¼ 6 of 116, 5.2%). Onset
of 79% of SCI events (19 of 24) was delayed (>6 h post-
operative), were transient in 62.5% (15 of 24), and symp-
toms resolved within a median of 1 day (interquartile
range, 1-3.5 days). Prolonged postoperative hypotension
was associated with SCI (odds ratio, 5.0; 95% conﬁdence
interval, 1.6-16.1; P < .01). Aneurysm extent or the pres-
ence of a postoperative endoleak was not associated with
SCI events. The change in C-reactive protein levels from
baseline to peak was 1.8-times greater in patients with
SCI than those without (P ¼ .03).
Conclusions: Most episodes of SCI after MBEVAR
are transient and do not occur in the operating room.
Increased systemic inﬂammation may have an adverse effect
on spinal cord perfusion and play a role in the delayed onset
of SCI. Current adjunct strategies to maintain spinal cord
perfusion, including permissive hypertension and CSF
drainage, may help prevent permanent SCI.
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Objectives: Endovascular repair (EVAR) of ruptured
abdominal aortic aneurysms (RAAA) is reported to have a
lower postoperative mortality than open repair (OR).
However, comparisons have involved heterogeneous
populations that lack adjustment for preoperative risk.
We hypothesize that for RAAA patients stratiﬁed by
a validated measure of preoperative mortality risk,
EVAR has a lower in-hospital mortality and morbidity
than does OR.
Methods: In-hospital mortality and morbidity after
EVAR and OR of RAAA were compared in patients from
the Vascular Quality Initiative (2003-2013) stratiﬁed by
the validated Vascular Study Group of New England
(VSGNE) RAAA Risk Score into low (score 0-1), moder-
ate (score 2-3), and high (score 4-6) risk groups.
Results: Among 592 patients who underwent EVAR
and 703 patients who underwent OR of RAAA, EVAR
had lower in-hospital mortality (23% vs 36%, P < .001).
In risk-stratiﬁed patients, EVAR trended towards a lower
mortality in the low risk group (n ¼ 631; EVAR 11% vs
OR 16%; P ¼ .07), had a signiﬁcantly lower mortality in
the moderate risk group (n ¼ 460; EVAR 37% vs OR
48%; P ¼ .02), and no advantage in the high risk group
(n ¼ 84; EVAR 95% vs OR 80%; P ¼ .17). Across all
risk groups, cardiac complications (EVAR: 28% vs OR:
38%; P ¼ .0003), respiratory complications (EVAR: 27%
vs OR: 46%; P < .0001), renal insufﬁciency (EVAR: 23%
vs OR: 37%; P < .0001), and bowel ischemia (EVAR: 4%
vs OR: 10%; P < .0001) were reduced signiﬁcantly after
EVAR. Across all risk groups, intensive care unit length
of stay (LOS) for EVAR (2 days; interquartile range
[IQR], 1-5 days) vs OR (6 days; IQR, 4-13 days; P <
.0001) and hospital LOS for EVAR (5 days; IQR, 3-11
days) vs OR (13 days; IQR, 8-22 days; P < .0001) were
lower after EVAR than OR.
Conclusions: This ﬁrst risk-stratiﬁed comparison us-
ing a national clinical database shows that EVAR of
RAAA has a lower mortality and morbidity compared
with OR in patients of low and moderate risk, and EVAR
should be used to treat these patients when feasible. For
RAAA patients at highest preoperative risk, there is no
beneﬁt to using EVAR compared with OR.
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